Trial · NCT00912964
Results by group666
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 666
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline to End of Treatment (Final Visit) in Mean Number of Incontinence Episodes Per 24 Hours | Placebo | -0.96 | Standard Error 0.122 | Incontinence episodes | |
| Change From Baseline to End of Treatment (Final Visit) in Mean Number of Incontinence Episodes Per 24 Hours | Mirabegron 25 mg | -1.36 | Standard Error 0.124 | Incontinence episodes | |
| Change From Baseline to End of Treatment (Final Visit) in Mean Number of Incontinence Episodes Per 24 Hours | Mirabegron 50 mg | -1.38 | Standard Error 0.123 | Incontinence episodes | |
| Change From Baseline to End of Treatment (Final Visit) in Mean Volume Voided Per Micturition | Placebo | 8.3 | Standard Error 2.23 | mL | |
| Change From Baseline to End of Treatment (Final Visit) in Mean Volume Voided Per Micturition | Mirabegron 25 mg | 12.8 | Standard Error 2.24 | mL | |
| Change From Baseline to End of Treatment (Final Visit) in Mean Volume Voided Per Micturition | Mirabegron 50 mg | 20.7 | Standard Error 2.20 | mL | |
| Change From Baseline to End of Treatment (Final Visit) in Mean Number of Micturitions Per 24 Hours | Placebo | -1.18 | Standard Error 0.124 | micturitions | |
| Change From Baseline to End of Treatment (Final Visit) in Mean Number of Micturitions Per 24 Hours | Mirabegron 25 mg | -1.65 | Standard Error 0.125 | micturitions | |
| Change From Baseline to End of Treatment (Final Visit) in Mean Number of Micturitions Per 24 Hours | Mirabegron 50 mg | -1.60 | Standard Error 0.122 | micturitions | |
| Change From Baseline to Week 4 in Mean Number of Incontinence Episodes Per 24 Hours | Placebo | -0.62 | Standard Error 0.120 | Incontinence episodes | |
| Change From Baseline to Week 4 in Mean Number of Incontinence Episodes Per 24 Hours | Mirabegron 25 mg | -0.96 | Standard Error 0.122 | Incontinence episodes | |
| Change From Baseline to Week 4 in Mean Number of Incontinence Episodes Per 24 Hours | Mirabegron 50 mg | -1.13 | Standard Error 0.122 | Incontinence episodes | |
| Change From Baseline to Week 4 in Mean Number of Micturitions Per 24 Hours | Placebo | -0.78 | Standard Error 0.124 | micturitions | |
| Change From Baseline to Week 4 in Mean Number of Micturitions Per 24 Hours | Mirabegron 25 mg | -0.96 | Standard Error 0.124 | micturitions | |
| Change From Baseline to Week 4 in Mean Number of Micturitions Per 24 Hours | Mirabegron 50 mg | -1.14 | Standard Error 0.122 | micturitions | |
| Change From Baseline to End of Treatment (Final Visit) in Mean Level of Urgency | Placebo | -0.15 | Standard Error 0.028 | scores on a scale | |
| Change From Baseline to End of Treatment (Final Visit) in Mean Level of Urgency | Mirabegron 25 mg | -0.22 | Standard Error 0.029 | scores on a scale | |
| Change From Baseline to End of Treatment (Final Visit) in Mean Level of Urgency | Mirabegron 50 mg | -0.29 | Standard Error 0.028 | scores on a scale | |
| Change From Baseline to End of Treatment (Final Visit) in Mean Number of Urgency Incontinence Episodes Per 24 Hours | Placebo | -0.95 | Standard Error 0.110 | urgency incontinence episodes | |
| Change From Baseline to End of Treatment (Final Visit) in Mean Number of Urgency Incontinence Episodes Per 24 Hours | Mirabegron 25 mg | -1.31 | Standard Error 0.112 | urgency incontinence episodes |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00912964/results